What is the highest possible stock price for Synthetic Biologics?
On average, they expect Synthetic Biologics' stock price to reach $2.50 in the next year. This suggests a possible upside of 682.7% from the stock's current price. View analysts' price targets for Synthetic Biologics or view top-rated stocks among Wall Street analysts. Who are Synthetic Biologics' key executives?
What is the price of synapse in USD?
The live Synapse price today is $2.29 USD with a 24-hour trading volume of $2,517,318 USD. We update our SYN to USD price in real-time.
What is synapse (syn) token?
As the native token of the Synapse Chain, SYN may also be used to pay for transactions within the network as well as for bridging to other chains. What Is a Crypto Faucet? What Are Crypto Debit Cards?
Is syn stock a good buy?
Synthetic Biologics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Should I invest in synthetic biologics?
Synthetic Biologics has 320.88% upside potential, based on the analysts' average price target. Can I see which stocks the top-ranking analysts are rating? Yes, go to the Analysts' Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
Will Synthetic Biologics stock go Up?
Stock Price Forecast The 2 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 1.63, with a high estimate of 2.25 and a low estimate of 1.00. The median estimate represents a +608.68% increase from the last price of 0.23.
What happened to Synthetic Biologics?
Synthetic Biologics has lost its breakthrough designation for ribaxamase following a review of the data by the FDA. The review focused on an imbalance in patient deaths in a phase 2b trial of the drug, leading the FDA to conclude ribaxamase no longer meets the requirements for its breakthrough status.
Should I buy or sell Synthetic Biologics stock right now?
1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Synthetic Biologics in the last twelve months. There are...
What is Synthetic Biologics' stock price forecast for 2022?
1 analysts have issued twelve-month price objectives for Synthetic Biologics' shares. Their forecasts range from $2.25 to $2.50. On average, they p...
How has Synthetic Biologics' stock performed in 2022?
Synthetic Biologics' stock was trading at $0.27 at the beginning of the year. Since then, SYN stock has decreased by 22.2% and is now trading at $0...
Are investors shorting Synthetic Biologics?
Synthetic Biologics saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 1,150,000 shares, a drop of...
When is Synthetic Biologics' next earnings date?
Synthetic Biologics is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our earnings forecast for...
How were Synthetic Biologics' earnings last quarter?
Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) announced its quarterly earnings results on Monday, May, 16th. The company reported ($0.03) earnings p...
When did Synthetic Biologics' stock split? How did Synthetic Biologics' stock split work?
Synthetic Biologics's stock reverse split on Monday, August 13th 2018. The 1-35 reverse split was announced on Wednesday, August 1st 2018. The numb...
Who are Synthetic Biologics' key executives?
Synthetic Biologics' management team includes the following people: Mr. Steven A. Shallcross CPA , CEO, CFO, Treasurer, Corp. Sec. & Director (A...
Who are some of Synthetic Biologics' key competitors?
Some companies that are related to Synthetic Biologics include Annexon (ANNX) , Pieris Pharmaceuticals (PIRS) , Wave Life Sciences (WVE) , Next...
What is the purpose of the SYN-004?
What is synthetic biologics?
The SYN-004, which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antimicrobial resistance.
What is Synthetic Biologics' stock symbol?
is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004. The SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation. The SYN-004, which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antimicrobial resistance. The company was founded by Steven H. Kanzer in January 2001 and is headquartered in Rockville, MD.
How many shares of synthetic biologics are there after the split?
Synthetic Biologics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SYN."
When did Synthetic Biologics' stock split? How did Synthetic Biologics' stock split work?
An investor that had 100 shares of Synthetic Biologics stock prior to the reverse split would have 3 shares after the split.
What other stocks do shareholders of Synthetic Biologics own?
Synthetic Biologics's stock reverse split before market open on Monday, August 13th 2018. The 1-35 reverse split was announced on Wednesday, August 1st 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 10th 2018. An investor that had 100 shares of Synthetic Biologics stock prior to the reverse split would have 3 shares after the split.
How much money does Synthetic Biologics make?
Based on aggregate information from My MarketBeat watchlists, some companies that other Synthetic Biologics investors own include Synergy Pharmaceuticals (SGYP), Tonix Pharmaceuticals (TNXP), Agenus (AGEN), Palatin Technologies (PTN), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), CorMedix (CRMD), Idera Pharmaceuticals (IDRA), Ampio Pharmaceuticals (AMPE) and Navidea Biopharmaceuticals (NAVB).
Where are Synthetic Biologics' headquarters?
Synthetic Biologics has a market capitalization of $33.38 million. The company earns $-10.04 million in net income (profit) each year or ($0.31) on an earnings per share basis.
When will synthetic biologics release earnings?
Synthetic Biologics is headquartered at 617 Detroit St Ste 100, ANN ARBOR, MI 48104-1125, United States .
What is synthetic biologics?
Synthetic Biologics is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021. View our earnings forecast for Synthetic Biologics.
How to calculate restricted stock?
Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004. The SYN-010, which is intended to reduce...
What is dividend percentage?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
What are the different grades for stocks?
A company's dividend expressed as a percentage of its current stock price.
How many X is Zacks?
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
What is style score?
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
How many sectors are there in Zacks?
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
Is ZacksTrade a separate company?
The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank.
